April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Differential roles of Pannexin-1 mediated signaling in the regulation of lacrimal gland morphogenesis and inflammation
Author Affiliations & Notes
  • Helen P Makarenkova
    Cell and Molecular Biology, Scripps Research Institute, La Jolla, CA
  • Pamela Imperadore
    Cell and Molecular Biology, Scripps Research Institute, La Jolla, CA
  • Driss Zoukhri
    General Dentistry, Tufts University School of Dental Medicine, Boston, MA
  • Valery Shestopalov
    Ophthalmology, Bascom Palmer Eye Institute University of Miami School of Medicine, Miami, FL
    Vavilov Institute for General Genetics, Moscow, Russian Federation
  • Footnotes
    Commercial Relationships Helen Makarenkova, None; Pamela Imperadore, None; Driss Zoukhri, None; Valery Shestopalov, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 52. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Helen P Makarenkova, Pamela Imperadore, Driss Zoukhri, Valery Shestopalov, NT; Differential roles of Pannexin-1 mediated signaling in the regulation of lacrimal gland morphogenesis and inflammation. Invest. Ophthalmol. Vis. Sci. 2014;55(13):52.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Sjögren’s syndrome is a systemic chronic autoimmune inflammatory disease that targets primarily the salivary and lacrimal glands (LG). Recent data indicates that pannexin hemichannels are involved in signaling events leading to inflammation and cell death. At the same time Panx1 is implicated in healing process since it facilitates progenitor cell proliferation and differentiation during tissue regeneration. No specific role for Panx1 and other pannexins has been defined in the LG.

Methods: Gene expression in murine LG was examined by qRT-PCR and immunostaining. Panx1 blocking peptide or saline (control) were co-administrated together with IL-1α injection. FACS isolated epithelial progenitors were used in transplantation experiments. Comparison of Panx1-null and WT LG morphology was performed using sections analysis.

Results: Panx1 and 2 isoforms were expressed in the epithelial component of the LG; Panx2 labeling was also detectable in the blood vessels. Panx1 expression was also studied in the IL-1α injured LGs. IL-1α induces a strong immune response, extensive inflammation, and LG damage, followed by a regenerative phase. Panx1 was strongly induced during acute phase of LG inflammation and regeneration, peaking at 3 days and declining to the baseline level during 7 to 21 days post injury. Analysis of epithelial progenitor cells transplantation into IL-1α injured LG showed that efficiency of progenitor cell engraftment varied, depending on timing of cell injection. The lowest efficiency (1.43 ± 0.07%) of cell engraftment was found at one day after the injury, during acute LG inflammation. To test whether manipulation of Panx1 expression/function during injury-induced inflammation affects cell engraftment; we blocked Panx1 expression during LG inflammation phase. This manipulation increased engraftment of donor progenitor cells by approximately 63% relative to control. Genetic ablation of the Panx1 gene affected overall LG morphology and caused significant LG size reduction in Panx1-null mice, suggesting a specific role for Panx1 in LG morphogenesis. These data suggest that Panx1 mediated signaling may play distinct roles during different phases of LG inflammation and development/regeneration.

Conclusions: Panx1 hemichanells are implicated in IL1-induced LG inflammatory injury and also may play a distinct role in LG morphogenesis and regeneration.

Keywords: 576 lacrimal gland • 447 cell-cell communication • 721 stem cells  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.